Correlation Between Cipher Pharmaceuticals and Biosyent

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cipher Pharmaceuticals and Biosyent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cipher Pharmaceuticals and Biosyent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cipher Pharmaceuticals and Biosyent, you can compare the effects of market volatilities on Cipher Pharmaceuticals and Biosyent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cipher Pharmaceuticals with a short position of Biosyent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cipher Pharmaceuticals and Biosyent.

Diversification Opportunities for Cipher Pharmaceuticals and Biosyent

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cipher and Biosyent is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Cipher Pharmaceuticals and Biosyent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biosyent and Cipher Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cipher Pharmaceuticals are associated (or correlated) with Biosyent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biosyent has no effect on the direction of Cipher Pharmaceuticals i.e., Cipher Pharmaceuticals and Biosyent go up and down completely randomly.

Pair Corralation between Cipher Pharmaceuticals and Biosyent

Assuming the 90 days trading horizon Cipher Pharmaceuticals is expected to under-perform the Biosyent. In addition to that, Cipher Pharmaceuticals is 1.89 times more volatile than Biosyent. It trades about -0.09 of its total potential returns per unit of risk. Biosyent is currently generating about 0.04 per unit of volatility. If you would invest  1,138  in Biosyent on August 29, 2024 and sell it today you would earn a total of  14.00  from holding Biosyent or generate 1.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Cipher Pharmaceuticals  vs.  Biosyent

 Performance 
       Timeline  
Cipher Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cipher Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Biosyent 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Biosyent are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Biosyent may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Cipher Pharmaceuticals and Biosyent Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cipher Pharmaceuticals and Biosyent

The main advantage of trading using opposite Cipher Pharmaceuticals and Biosyent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cipher Pharmaceuticals position performs unexpectedly, Biosyent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biosyent will offset losses from the drop in Biosyent's long position.
The idea behind Cipher Pharmaceuticals and Biosyent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.